Clinical Trial Search - Liver Disease - CPL (US)
$14.25 CPLdead
MaxBounty · Health & Wellness / Clinical Trials & Research · US · live 36 days
Model this payoutPrefills the fixed conversion payout; your traffic assumptions stay in your browser.
Run this offer — join MaxBounty →
Should you run this?
- ⚖️ Payout vs its vertical: beats 13% of the 3666 live Health & Fitness offers we track (vertical median $26.26).
Payout history
🔒 1 older event is hidden — create a free account to see this offer's full payout history.
Description
This study is testing an investigational oral medication for various liver diseases.
Converts on qualified lead submission
Targeting: Consumers aged 18–65 who have a physician diagnosis of a liver condition such as Cirrhosis, NAFLD/NASH, Fibrosis, or Hemochromatosis.
Restrictions: ALL COPY AND CREATIVE must be submitted for compliance approval before going live. Participants must not have been diagnosed with Chronic Hepatitis B or C, nor have been treated with Methotrexate. No incentive traffic is permitted.
Converts on qualified lead submission
Targeting: Consumers aged 18–65 who have a physician diagnosis of a liver condition such as Cirrhosis, NAFLD/NASH, Fibrosis, or Hemochromatosis.
Restrictions: ALL COPY AND CREATIVE must be submitted for compliance approval before going live. Participants must not have been diagnosed with Chronic Hepatitis B or C, nor have been treated with Methotrexate. No incentive traffic is permitted.
Change log (5 events)
🔒 1 older event is hidden — create a free account to see this offer's full payout history.
| Observed | Type | Field | Old | New |
|---|---|---|---|---|
| 8/2/2026 | epc_changed | epc | -1 | 0.35625 |
| 8/10/2026 | epc_changed | epc | 0.3563 | 1.8148314606741573 |
| 8/11/2026 | epc_changed | epc | 1.8148 | 1.4818348623853212 |
| 8/13/2026 | offer_dead | status | active | dead |
Reviews (0)
No reviews yet — be the first to share your experience.
Log in or create a free account to review this offer.
Payout looks wrong or a link is dead? Report a problem with this offer — we check it against the source.